American Pie star Jason Biggs flaunted his trim new figure during an appearance at the City Harvest Carnaval-themed Gala in New York City on Tuesday, April 22.
Biggs credited his transformation to a journey toward improved health, revealing in an interview with Page Six that he had been facing "some cholesterol issues" prior to the weight loss.
After dropping 35 pounds—and cutting back on some of the "ice cream pints [he] would knock back"—the Orange Is the New Black actor managed to drop his cholesterol by 70 points.
“It’s been a journey,” the 46-year-old admitted, having altered both his diet and his workout routine to achieve his results. He was unable to specify exactly how long his health was a work in progress, noting it had been "a while" since he began his journey.
In photos from the charity event, Biggs wore a sleek blue suit. With his face covered in just a 5 o'clock shadow, the weight loss was obvious, with his cheek bones stealing the show.
He hasn't completely given up on treats to maintain his new appearance, though, admitting to the publication that he still abides by his sweet tooth on occasion—especially when it comes to his favorite gelato shop in the West Village.
Hence then, the article about jason biggs unveils impressive weight loss following health issues was published today ( ) and is available on Parade ( Saudi Arabia ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Jason Biggs Unveils Impressive Weight Loss Following Health 'Issues' )
Also on site :
- Mom signs up daughter for Angel Tree. Then she sees what she got. Now she’s on the ‘ungrateful’ list: ‘Looks like they came from the Dollar Tree’
- Supermarket timings for Boxing Day and New Year revealed for Asda, Tesco, Sainsbury’s, Aldi, Lidl and more
- ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly